Article
Impact of SLCO1B1 521T > C variant on leucovorin rescue and risk of relapse in childhood acute lymphoblastic leukemia treated with high-dose methotrexate.
Pediatric blood & cancer - 1 Dec 2014
Zhang Hua-Nian, He Xue-Lian, Wang Cheng, Wang Yang, Chen Yu-Jun, Li Jian-Xin, Niu Chang-He, Gao Ping
Abstract excerpt
BACKGROUND: Recent studies suggest that SLCO1B1 c.521T > C variant decreases the clearance of methotrexate (MTX) and elevates its plasma concentration, hence leucovorin doses may need to be adjusted. However, high leucovorin doses may affect the cure rate in childhood acute lymphoblastic leukemia (ALL). Hitherto neither the appropriate dose of leucovorin in carriers of SLCO1B1 c.521T > C variant nor the impact of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
